A 42-year-old woman presents to the emergency department with a severe, throbbing headache… — USMLE Step 3

A $42$ -year-old woman presents to the emergency department with a severe, throbbing headache and blurred vision that started earlier today. She has a $3$ -year history of diffuse cutaneous systemic sclerosis and Raynaud phenomenon. Two weeks ago, she was evaluated in the rheumatology clinic for worsening joint pain and skin tightness, and a new oral medication was prescribed. Vital signs are temperature $37.1^\circ\text{C}$ ( $98.8^\circ\text{F}$ ), blood pressure $218/116\text{ mm Hg}$ , heart rate $105/\text{min}$ , and respiratory rate $18/\text{min}$ . Physical examination reveals diffusely thickened, tight skin over the face, chest, and extremities. Funduscopic examination shows bilateral flame-shaped hemorrhages and papilledema. Laboratory studies show:

Hemoglobin: $9.8\text{ g/dL}$
Platelet count: $110,000/\text{mm}^3$
Serum creatinine: $3.4\text{ mg/dL}$ (baseline $0.8\text{ mg/dL}$ )
Blood urea nitrogen: $45\text{ mg/dL}$

A peripheral blood smear reveals $3$ to $5$ schistocytes per high-power field.

Which of the following is the most appropriate initial pharmacologic intervention?

Initiate oral captoprilAnswer
B
Administer intravenous labetalol
C
Administer intravenous methylprednisolone
D
Initiate therapeutic plasma exchange
E
Administer intravenous nitroprusside

Answer

Initiate oral captopril

The correct intervention is initiating oral captopril. This patient is presenting with scleroderma renal crisis (SRC), which is characterized by the sudden onset of marked hypertension, acute kidney injury, and frequently, microangiopathic hemolytic anemia (indicated by schistocytes and thrombocytopenia). SRC is a life-threatening complication most common in patients with diffuse cutaneous systemic sclerosis. The crisis is often precipitated by the use of glucocorticoids. The underlying mechanism is intense renal vasospasm that leads to massive activation of the renin-angiotensin-aldosterone system (RAAS). Because the pathology is entirely driven by renin, the standard of care is immediate initiation of a short-acting ACE inhibitor, such as captopril. Crucially, the ACE inhibitor must be started and titrated even in the face of a rising creatinine level, making this a highly specific exception to the general rule of avoiding ACE inhibitors in acute kidney injury.

Step-by-Step Solution

Identify the primary clinical syndrome based on the patient's history and acute presentation.

The patient has severe hypertension, acute kidney injury, and microangiopathic hemolytic anemia (MAHA) in the setting of diffuse cutaneous systemic sclerosis.

These findings are the classic triad for scleroderma renal crisis (SRC), likely precipitated by the recent introduction of glucocorticoids for her joint pain.

Determine the underlying pathophysiology of the identified syndrome.

SRC is driven by intense renal vascular spasm and intimal proliferation, which leads to ischemia of the juxtaglomerular apparatus and massive, uncontrolled release of renin.

Understanding that RAAS hyperactivation is the core mechanism dictates the necessity for a specific targeted therapy rather than generic blood pressure reduction.

Select the optimal pharmacologic intervention to reverse the pathophysiology.

A short-acting ACE inhibitor, specifically captopril, must be initiated immediately.

Unlike typical scenarios where ACE inhibitors are held in acute kidney injury, captopril is uniquely indicated in SRC to break the cycle of renin-induced vasospasm and salvage renal function.

Key Concept

Scleroderma renal crisis is a life-threatening complication characterized by malignant hypertension and oliguric acute kidney injury, driven by extreme RAAS activation, and it requires immediate initiation of an ACE inhibitor (e.g., captopril) despite the presence of renal impairment.

Question

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Topics

More questions from this topic